Also all those posts going on about FDA won’t approve it - when they hadn’t even had the data yet
The FDA wasn't happy with the first phase III trial because of the manufacturing error that caused some subjects to get different doses, so they asked AZ to redo the trial in the US. That's been done and the FDA will have no problem moving forward with EUA if there are no surprises in the data.
This is also fortuitous because it proves that all of the concerns about blood clots, lower effectiveness in the over 65 cohort, etc. are completely unfounded. When the EUA is granted that should go a long way to restoring confidence in the vaccine.